Mesenchymal stem cells attenuate doxorubicin‑induced cellular senescence through the VEGF/Notch/TGF‑β signaling pathway in H9c2 cardiomyocytes

Chen,Lingli; Xia,Wenzheng; Hou,Meng

doi:10.3892/ijmm.2018.3635

Mesenchymal stem cells attenuate doxorubicin‑induced cellular senescence through the VEGF/Notch/TGF‑β signaling pathway in H9c2 cardiomyocytes

Authors:
- Lingli Chen
- Wenzheng Xia
- Meng Hou
View Affiliations

Affiliations: Department of Neurology, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China, Department of Neurosurgery, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China, Department of Radiation Oncology, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China
Published online on: April 19, 2018 https://doi.org/10.3892/ijmm.2018.3635
Pages: 674-684

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The clinical use of doxorubicin (Dox) is limited by its cardiotoxicity. The fundamental changes it induces include interstitial myocardial fibrosis and the appearance of senescent cardiomyocytes. Mesenchymal stem cell (MSC)‑based therapies have also been reported to modulate cellular senescence, and have been used effectively to treat age‑related cardiovascular diseases. In the present study, the Transwell system was used to coculture H9c2 cells with MSCs, and their proliferation and viability were assessed. The expression of senescence‑related genes p53 and p16, and telomere length were measured using reverse transcription‑quantitative polymerase chain reaction analysis, and the Jagged‑1/Notch‑1 signaling pathway was detected using western blot analysis. The results revealed that Dox induced the senescence of H9c2 cells, characterized by a low proliferation rate, poor viability, reduced telomere length and impaired telomerase activity, and by marked increases in the expression of p53 and p16. By contrast, when cocultured with MSCs in the presence of Dox, H9c2 cell proliferation and viability increased, whereas the expression levels of p53 and p16 decreased, and telomere length and telomerase activity increased. The mechanism underlying the antisenescence function of MSCs was clarified, which involved the vascular endothelial growth factor (VEGF)/Jagged‑1/Notch‑1/transforming growth factor‑β1 (TGF‑β1) signaling pathway. It was confirmed that inhibiting VEGF, or silencing Jagged‑1 or Notch‑1 with small interfering RNA, or using recombinant TGF‑β1 eliminated the antisenescence effects of MSCs on the Dox‑treated H9c2 cells. The results revealed that MSCs rescued H9c2 cells from Dox‑induced senescence through the release of VEGF, which activated the Jagged‑1/Notch‑1 signaling pathway, leading to the inhibition of TGF‑β1 release. Therefore, treatment with MSCs may have important therapeutic implications on the attenuation of cardiotoxicity in patients with cancer treated with Dox.

View Figures

View References

1	Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ and Moens AL: Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol. 52:1213–1225. 2012. View Article : Google Scholar : PubMed/NCBI
2	Carvalho C, Santos RX, Cardoso S, Correia S, Oliveira PJ, Santos MS and Moreira PI: Doxorubicin: The good, the bad and the ugly effect. Curr Med Chem. 16:3267–3285. 2009. View Article : Google Scholar : PubMed/NCBI
3	Stěrba M, Popelová O, Vávrová A, Jirkovský E, Kovaříková P, Geršl V and Simůnek T: Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection. Antioxid Redox Signal. 18:899–929. 2013. View Article : Google Scholar
4	Singh P, Sharma R, McElhanon K, Allen CD, Megyesi JK, Beneš H and Singh SP: Sulforaphane protects the heart from doxorubicin-induced toxicity. Free Radic Biol Med. 86:90–101. 2015. View Article : Google Scholar : PubMed/NCBI
5	Guarita-Souza LC, Teixeira de Carvalho KA, Francisco JC, Simeoni R and Faria-Neto JR: Cellular transplantation for the treatment of non-ischaemic dilated cardiomyopathies. Eur Heart J Suppl. 10:K7–K10. 2008. View Article : Google Scholar
6	Mohammadi Gorji S, Karimpor Malekshah AA, Hashemi-Soteh MB, Rafiei A, Parivar K and Aghdami N: Effect of mesenchymal stem cells on doxorubicin-induced fibrosis. Cell J. 14:142–151. 2012.
7	Ezquer F, Gutiérrez J, Ezquer M, Caglevic C, Salgado HC and Calligaris SD: Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: Hopes and fears. Stem Cell Res Ther. 6:1162015. View Article : Google Scholar : PubMed/NCBI
8	Garbade J, Dhein S, Lipinski C, Aupperle H, Arsalan M, Borger MA, Barten MJ, Lehmann S, Walther T and Mohr FW: Bone marrow-derived stem cells attenuate impaired contractility and enhance capillary density in a rabbit model of doxorubicin-induced failing hearts. J Card Surg. 24:591–599. 2009. View Article : Google Scholar : PubMed/NCBI
9	Tian Y, Xu Y, Xue T, Chen L, Shi B, Shu B, Xie C, Max Morandi M, Jaeblon T, Marymont JV and Dong Y: Notch activation enhances mesenchymal stem cell sheet osteogenic potential by inhibition of cellular senescence. Cell Death Dis. 8:e25952017. View Article : Google Scholar : PubMed/NCBI
10	Iglesias-Bartolome R and Gutkind JS: Signaling circuitries controlling stem cell fate: To be or not to be. Curr Opin Cell Biol. 23:716–723. 2011. View Article : Google Scholar : PubMed/NCBI
11	Towbin JA, Lorts A and Jefferies JL: Left ventricular non-compaction cardiomyopathy. Lancet. 386:813–825. 2015. View Article : Google Scholar : PubMed/NCBI
12	Gude N, Joyo E, Toko H, Quijada P, Villanueva M, Hariharan N, Sacchi V, Truffa S, Joyo A, Voelkers M, et al: Notch activation enhances lineage commitment and protective signaling in cardiac progenitor cells. Basic Res Cardiol. 110:292015. View Article : Google Scholar : PubMed/NCBI
13	Ieronimakis N, Hays AL, Janebodin K, Mahoney WM Jr, Duffield JS, Majesky MW and Reyes M: Coronary adventitial cells are linked to perivascular cardiac fibrosis via TGFβ1 signaling in the mdx mouse model of duchenne muscular dystrophy. J Mol Cell Cardiol. 63:122–134. 2013. View Article : Google Scholar : PubMed/NCBI
14	Castañares C, Redondo-Horcajo M, Magán-Marchal N, Ten Dijke P, Lamas S and Rodríguez-Pascual F: Signaling by ALK5 mediates TGF-beta-induced ET-1 expression in endothelial cells: A role for migration and proliferation. J Cell Sci. 120:1256–1266. 2007. View Article : Google Scholar : PubMed/NCBI
15	Konorev EA, Vanamala S and Kalyanaraman B: Differences in doxorubicin-induced apoptotic signaling in adult and immature cardiomyocytes. Free Radic Biol Med. 45:1723–1728. 2008. View Article : Google Scholar : PubMed/NCBI
16	Hou J, Wang L, Hou J, Guo T, Xing Y, Zheng S, Zhou C, Huang H, Long H, Zhong T, et al: Peroxisome proliferator-activated receptor gamma promotes mesenchymal stem cells to express connexin43 via the inhibition of tgf-β1/smads signaling in a rat model of myocardial infarction. Stem Cell Rev. 11:885–899. 2015. View Article : Google Scholar : PubMed/NCBI
17	Witek P, Korga A, Burdan F, Ostrowska M, Nosowska B, Iwan M and Dudka J: The effect of a number of H9C2 rat cardiomyocytes passage on repeatability of cytotoxicity study results. Cytotechnology. 68:2407–2415. 2016. View Article : Google Scholar : PubMed/NCBI
18	Xia W, Zhang F, Xie C, Jiang M and Hou M: Macrophage migration inhibitory factor confers resistance to senescence through cd74-dependent ampk-foxo3a signaling in mesenchymal stem cells. Stem Cell Res Ther. 6:822015. View Article : Google Scholar : PubMed/NCBI
19	Hou M, Liu J, Liu F, Liu K and Yu B: C1q tumor necrosis factor-related protein-3 protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis through the phosphoinositide 3-kinase/Akt pathway. Int J Mol Med. 33:97–104. 2014. View Article : Google Scholar
20	Piegari E, Russo R, Cappetta D, Esposito G, Urbanek K, Dell’Aversana C, Altucci L, Berrino L, Rossi F and De Angelis A: MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat. Oncotarget. 7:62312–62326. 2016. View Article : Google Scholar : PubMed/NCBI
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-(Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
22	Xia W and Hou M: Macrophage migration inhibitory factor rescues mesenchymal stem cells from doxorubicin-induced senescence though the PI3K-Akt signaling pathway. Int J Mol Med. 41:1127–1137. 2018.
23	Kourembanas S: Exosomes: Vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. Annu Rev Physiol. 77:13–27. 2015. View Article : Google Scholar
24	Xu LL, Fu HX, Zhang JM, Feng FE, Wang QM, Zhu XL, Xue J, Wang CC, Chen Q, Liu X, et al: Impaired function of bone marrow mesenchymal stem cells from immune thrombocytopenia patients in inducing regulatory dendritic cell differentiation through the Notch-1/Jagged-1 signaling pathway. Stem Cell Dev. 26:1648–1661. 2017. View Article : Google Scholar
25	Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni CA, Veglia F, Civelli M, Lamantia G, Colombo N, Curigliano G, et al: Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 131:1981–1988. 2015. View Article : Google Scholar : PubMed/NCBI
26	Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, Hagerty KL, Somerfield MR and Vaughn DJ; ASCO Cancer Survivorship Expert Panel: American society of clinical oncology clinical evidence review on the ongoing care of adult cancer survivors: Cardiac and pulmonary late effects. J Clin Oncol. 25:3991–4008. 2007. View Article : Google Scholar : PubMed/NCBI
27	Du WW, Yang W, Chen Y, Wu ZK, Foster FS, Yang Z, Li X and Yang BB: Foxo3 circular RNA promotes cardiac senescence by modulating multiple factors associated with stress and senescence responses. Eur Heart J. 38:1402–1412. 2017.
28	Jackson JG, Pant V, Li Q, Chang LL, Quintás-Cardama A, Garza D, Tavana O, Yang P, Manshouri T, Li Y, et al: p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer. Cancer Cell. 21:793–806. 2012. View Article : Google Scholar : PubMed/NCBI
29	Baar MP, Brandt RMC, Putavet DA, Klein JDD, Derks KWJ, Bourgeois BRM, Stryeck S, Rijksen Y, van Willigenburg H, Feijtel DA, et al: Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. Cell. 169:132–147. 2017. View Article : Google Scholar : PubMed/NCBI
30	Mao C, Hou X, Wang B, Chi J, Jiang Y, Zhang C and Li Z: Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats. Stem Cell Res Ther. 8:182017. View Article : Google Scholar : PubMed/NCBI
31	Bollini S, Cheung KK, Riegler J, Dong X, Smart N, Ghionzoli M, Loukogeorgakis SP, Maghsoudlou P, Dubé KN, Riley PR, et al: amniotic fluid stem cells are cardioprotective following acute myocardial infarction. Stem Cells Dev. 20:1985–1994. 2011. View Article : Google Scholar : PubMed/NCBI
32	Lazzarini E, Balbi C, Altieri P, Pfeffer U, Gambini E, Canepa M, Varesio L, Bosco MC, Coviello D, Pompilio G, et al: The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity. Sci Rep. 6:299942016. View Article : Google Scholar : PubMed/NCBI
33	Zhou N, Fu Y, Wang Y, Chen P, Meng H, Guo S, Zhang M, Yang Z and Ge Y: p27kip1 haplo-insufficiency improves cardiac function in early-stages of myocardial infarction by protecting myocardium and increasing angiogenesis by promoting IKK activation. Sci Rep. 4:59782014. View Article : Google Scholar :
34	Rios C, D’Ippolito G, Curtis KM, Delcroix GJ, Gomez LA, El Hokayem J, Rieger M, Parrondo R, de Las Pozas A, Perez-Stable C, et al: Low oxygen modulates multiple signaling pathways increasing self-renewal while decreasing differentiation, senescence and apoptosis in stromal miami cells. Stem Cells Dev. 25:848–460. 2016. View Article : Google Scholar : PubMed/NCBI
35	Packard RRS, Baek KI, Beebe T, Jen N, Ding Y, Shi F, Fei P, Kang BJ, Chen PH, Gau J, et al: Automated segmentation of light-sheet fluorescent imaging to characterize experimental doxorubicin-induced cardiac injury and repair. Sci Rep. 7:86032017. View Article : Google Scholar
36	Chua S, Lee FY, Chiang HJ, Chen KH, Lu HI, Chen YT, Yang CC, Lin KC, Chen YL, Kao GS, et al: The cardioprotective effect of melatonin and exendin-4 treatment in a rat model of cardiorenal syndrome. J Pineal Res. 61:438–456. 2016. View Article : Google Scholar
37	Sun Z, Schriewer J, Tang M, Marlin J, Taylor F, Shohet RV and Konorev EA: The TGF-β pathway mediates doxorubicin effects on cardiac endothelial cells. J Mol Cell Cardiol. 90:129–138. 2016. View Article : Google Scholar
38	Cappetta D, Esposito G, Piegari E, Russo R, Ciuffreda LP, Rivellino A, Berrino L, Rossi F, De Angelis A and Urbanek K: SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy. Int J Cardiol. 205:99–110. 2016. View Article : Google Scholar : PubMed/NCBI
39	Li H, Xu D, Toh BH and Liu JP: TGF-beta and cancer: Is Smad3 a repressor of hTERT gene? Cell Res. 16:169–173. 2006. View Article : Google Scholar : PubMed/NCBI
40	Chen P, Wu R, Zhu W, Jiang Z, Xu Y, Chen H, Zhang Z, Chen H, Zhang L, Yu H, et al: Hypoxia preconditioned mesenchymal stem cells prevent cardiac fibroblast activation and collagen production via leptin. PloS one. 9:e1035872014. View Article : Google Scholar : PubMed/NCBI